ImmuCell Corporation Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
ImmuCell Corporation (ICCC) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $4.80 per share for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-26.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2015-03-26
- ImmuCell Corporation share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2014 was $4.80, a 2.35% increase from fiscal 2013.
- ImmuCell Corporation share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2013 was $4.69, a 24.96% decline from fiscal 2012.
- ImmuCell Corporation share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2012 was $6.25, a 8.70% increase from fiscal 2011.
- ImmuCell Corporation share-based payment arrangement, option, exercise price range, upper range limit for fiscal 2011 was $5.75.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 12 month |
|---|---|
| 2014-12-31 | $4.80 10-K · filed 2015-03-26 |
| 2013-12-31 | $4.69 10-K · filed 2015-03-26 |
| 2012-12-31 | $6.25 10-K · filed 2015-03-26 |
| 2011-12-31 | $5.75 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |